242 related articles for article (PubMed ID: 32919954)
41. Silencing PFKP inhibits starvation-induced autophagy, glycolysis, and epithelial mesenchymal transition in oral squamous cell carcinoma.
Chen G; Liu H; Zhang Y; Liang J; Zhu Y; Zhang M; Yu D; Wang C; Hou J
Exp Cell Res; 2018 Sep; 370(1):46-57. PubMed ID: 29894707
[TBL] [Abstract][Full Text] [Related]
42. Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.
de Oliveira SF; Ganzinelli M; Chilà R; Serino L; Maciel ME; Urban Cde A; de Lima RS; Cavalli IJ; Generali D; Broggini M; Damia G; Ribeiro EM
PLoS One; 2016; 11(1):e0145647. PubMed ID: 26751376
[TBL] [Abstract][Full Text] [Related]
43. Chidamide suppresses the glycolysis of triple negative breast cancer cells partially by targeting the miR‑33a‑5p‑LDHA axis.
Bai X; Jiang H; Han G; He Q
Mol Med Rep; 2019 Aug; 20(2):1857-1865. PubMed ID: 31257519
[TBL] [Abstract][Full Text] [Related]
44. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.
Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X
Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827
[TBL] [Abstract][Full Text] [Related]
45. Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
Sheng J; Xue X; Jiang K
Curr Mol Med; 2019; 19(2):147-155. PubMed ID: 30854965
[TBL] [Abstract][Full Text] [Related]
46. USP2 promotes cell migration and invasion in triple negative breast cancer cell lines.
Qu Q; Mao Y; Xiao G; Fei X; Wang J; Zhang Y; Liu J; Cheng G; Chen X; Wang J; Shen K
Tumour Biol; 2015 Jul; 36(7):5415-23. PubMed ID: 25687182
[TBL] [Abstract][Full Text] [Related]
47. MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.
Lee JY; Won HY; Park JH; Kim HY; Choi HJ; Shin DH; Kang JH; Woo JK; Oh SH; Son T; Choi JW; Kim S; Kim HY; Yi K; Jang KS; Oh YH; Kong G
J Clin Invest; 2015 May; 125(5):1801-14. PubMed ID: 25822021
[TBL] [Abstract][Full Text] [Related]
48. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
[TBL] [Abstract][Full Text] [Related]
49. PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism.
Lang L; Chemmalakuzhy R; Shay C; Teng Y
Adv Exp Med Biol; 2019; 1134():243-258. PubMed ID: 30919341
[TBL] [Abstract][Full Text] [Related]
50. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
[TBL] [Abstract][Full Text] [Related]
51. A novel biomarker C6orf106 promotes the malignant progression of breast cancer.
Jiang G; Zhang X; Zhang Y; Wang L; Fan C; Xu H; Miao Y; Wang E
Tumour Biol; 2015 Sep; 36(10):7881-9. PubMed ID: 25953261
[TBL] [Abstract][Full Text] [Related]
52. GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer.
Ni YB; Tsang JYS; Shao MM; Chan SK; Cheung SY; Tong J; To KF; Tse GM
Breast Cancer Res Treat; 2018 May; 169(1):25-32. PubMed ID: 29340880
[TBL] [Abstract][Full Text] [Related]
53. p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP.
Huang Y; Xiong C; Wang C; Deng J; Zuo Z; Wu H; Xiong J; Wu X; Lu H; Hao Q; Zhou X
Cell Rep; 2023 Nov; 42(11):113426. PubMed ID: 37967006
[TBL] [Abstract][Full Text] [Related]
54. Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry.
Choi J; Jung WH; Koo JS
Pathobiology; 2013; 80(1):41-52. PubMed ID: 22832328
[TBL] [Abstract][Full Text] [Related]
55. The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.
Xiao X; Huang X; Ye F; Chen B; Song C; Wen J; Zhang Z; Zheng G; Tang H; Xie X
Sci Rep; 2016 Feb; 6():21735. PubMed ID: 26902416
[TBL] [Abstract][Full Text] [Related]
56. The RANK Pathway in Advanced Breast Cancer: Does Src Play a Role?
Li R; Zhang K; Penedo TL; Kragel CP; Grizzle WE; Hameed O; Siegal GP; Wei S
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):42-50. PubMed ID: 26200837
[TBL] [Abstract][Full Text] [Related]
57. Oocyte-derived BMP15 and FGFs cooperate to promote glycolysis in cumulus cells.
Sugiura K; Su YQ; Diaz FJ; Pangas SA; Sharma S; Wigglesworth K; O'Brien MJ; Matzuk MM; Shimasaki S; Eppig JJ
Development; 2007 Jul; 134(14):2593-603. PubMed ID: 17553902
[TBL] [Abstract][Full Text] [Related]
58. Quercetin Impairs HuR-Driven Progression and Migration of Triple Negative Breast Cancer (TNBC) Cells.
Umar SM; Patra S; Kashyap A; Dev J R A; Kumar L; Prasad CP
Nutr Cancer; 2022; 74(4):1497-1510. PubMed ID: 34278888
[TBL] [Abstract][Full Text] [Related]
59. Personalizing breast cancer staging by the inclusion of ER, PR, and HER2.
Bagaria SP; Ray PS; Sim MS; Ye X; Shamonki JM; Cui X; Giuliano AE
JAMA Surg; 2014 Feb; 149(2):125-9. PubMed ID: 24306257
[TBL] [Abstract][Full Text] [Related]
60. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.
Li L; Kang L; Zhao W; Feng Y; Liu W; Wang T; Mai H; Huang J; Chen S; Liang Y; Han J; Xu X; Ye Q
Cancer Lett; 2017 Aug; 400():89-98. PubMed ID: 28461244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
